IonQ Inc (NYSE: IONQ) closed the day trading at $8.03 down -2.55% from the previous closing price of $8.24. On the day, 3591409 shares were traded.
Ratios:
For a better understanding of IONQ, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.49 and its Current Ratio is at 10.49. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on August 11, 2023, Reiterated its Buy rating but revised its target price to $21 from $12 previously.
On April 26, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $7.
On June 08, 2022, Needham started tracking the stock assigning a Buy rating and target price of $9.Needham initiated its Buy rating on June 08, 2022, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 11 ’24 when Chapman Peter Hume sold 29,452 shares for $10.20 per share. The transaction valued at 300,281 led to the insider holds 451,233 shares of the business.
Alameddine Rima sold 27,212 shares of IONQ for $277,443 on Mar 11 ’24. The CHIEF REVENUE OFFICER now owns 697,647 shares after completing the transaction at $10.20 per share. On Mar 11 ’24, another insider, Kramer Thomas G., who serves as the CHIEF FINANCIAL OFFICER of the company, sold 19,672 shares for $10.20 each. As a result, the insider received 200,568 and left with 954,224 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 75.87 while its Price-to-Book (P/B) ratio in mrq is 3.42.
Stock Price History:
Over the past 52 weeks, IONQ has reached a high of $21.60, while it has fallen to a 52-week low of $5.29.
Shares Statistics:
A total of 206.61M shares are outstanding, with a floating share count of 176.62M. Insiders hold about 16.43% of the company’s shares, while institutions hold 37.54% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from ProShares Trust ProShares S&P G analysts. The consensus estimate for the next quarter is $8.03, with high estimates of $0.68 and low estimates of $41.74.
Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Technology.
